FIT programmes | Positivity cut-off | Screenees | Adenomas | Advanced adenomas | CRC | PPV AN | |||
μg. Hb/g. faeces | N | N | % | N | % | N | ‰ | % | |
Czech Republic, women | 15 | 290.561 | 2.896 | 1.0 | 1.259 | 0.4 | 202 | 0.7 | 15.1 |
Czech Republic, men | 15 | 204.758 | 4.688 | 2.3 | 2.277 | 1.1 | 335 | 1.6 | 26.6 |
Czech Republic, all | 15 | 495.319 | 7.584 | 1.5 | 3.536 | 0.7 | 537 | 1.1 | 20.9 |
France Calvados, women | 180 | 13.455 | 112 | 0.8 | 62 | 0.5 | 18 | 1.3 | 23.1 |
France Calvados, men | 180 | 10.153 | 143 | 1.4 | 82 | 0.8 | 25 | 2.5 | 32.0 |
France Calvados, all | 180 | 23.608 | 255 | 1.1 | 144 | 0.6 | 43 | 1.8 | 27.5 |
Hungary, women | 20 | 4.450 | 89 | 2.0 | 0 | 0.0 | 9 | 2.0 | 4.4 |
Hungary, men | 20 | 3.416 | 163 | 4.8 | NA | 17 | 5.0 | 5.9 | |
Hungary, all | 20 | 7.866 | 252 | 3.2 | NA | 26 | 3.3 | 5.3 | |
Ireland, all | 20 | 23.511 | 686 | 2.9 | NA | 63 | 2.7 | 4.7 | |
Italy, women | 20 | 1.062.738 | 10.359 | 1.0 | 5.281 | 0.5 | 1.043 | 1.0 | 18.9 |
Italy, men | 20 | 906.793 | 17.604 | 1.9 | 9.210 | 1.0 | 1.495 | 1.6 | 26.8 |
Italy, all | 20 | 1.969.531 | 27.963 | 1.4 | 14.491 | 0.7 | 2.538 | 1.3 | 23.2 |
Malta, all | 20 | 6.754 | 116 | 1.7 | 0 | 15 | 2.2 | 0.3 | |
Netherlands, women* | 15–47 | 269.779 | 6.793 | 2.5 | 4.269 | 1.6 | 967 | 3.6 | 40.9 |
Netherlands, men* | 15–47 | 254.356 | 11.853 | 4.7 | 7.761 | 3.1 | 1.516 | 6.0 | 49.0 |
Netherlands, all* | 15–47 | 524.135 | 18.646 | 3.6 | 12.030 | 2.3 | 2.483 | 4.7 | 45.7 |
Slovenia, women | 20 (two samples) | 138.703 | 2.365 | 1.7 | 1.374 | 1.0 | 179 | 1.3 | 25.6 |
Slovenia, men | 20 (two samples) | 113.245 | 4.726 | 4.2 | 2.991 | 2.6 | 294 | 2.6 | 41.6 |
Slovenia, all | 20 (two samples) | 251.948 | 7.091 | 2.8 | 4.365 | 1.7 | 473 | 1.9 | 34.6 |
Spain, women | 20 | 241.529 | 5.028 | 2.1 | 3.134 | 1.3 | 457 | 1.9 | 31.2 |
Spain, men | 20 | 207.430 | 9.986 | 4.8 | 7.161 | 3.5 | 889 | 4.3 | 51.3 |
Spain, all | 20 | 448.959 | 15.014 | 3.3 | 10.295 | 2.3 | 1.346 | 3.0 | 42.8 |
*The Dutch data have been published in a paper presenting the results of the first year of screening activity.19
CRC, colorectal cancer; FIT, faecal immunochemical test; gFOBT, guaiac faecal occult blood test; PPV, positive predictive value.